Compare SPDR Kensho Final Frontiers ETF (ROKT) vs Revolution Medicines Inc. Common Stock (RVMD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
SPDR Kensho Final Frontiers ETF vs Revolution Medicines Inc. Common Stock — how do they compare? SPDR Kensho Final Frontiers ETF trades at $103.49 (market cap $170.14M), while Revolution Medicines Inc. Common Stock trades at $189.32 (market cap $40.32B). The key difference: Revolution Medicines Inc. Common Stock is far larger — about 237× SPDR Kensho Final Frontiers ETF's market cap, and Revolution Medicines Inc. Common Stock is trading nearer its 52-week high, SPDR Kensho Final Frontiers ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold SPDR Kensho Final Frontiers ETF for 9 Days and Revolution Medicines Inc. Common Stock for 0 Days on average.
| ROKT | RVMD | |
|---|---|---|
Market Cap | $170.14M | $40.32B |
Volume | 12,298 | 4,855,734 |
Sector | Sector/Thematic | Health |
52-Week High | $136.68 | $221.15 |
52-Week Low | $72.93 | $47.50 |
Typical Hold Time | 9 Days | 0 Days |
Enterprise Value | — | $37.02B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About SPDR Kensho Final Frontiers ETF
SPDR Kensho Final Frontiers ETF seeks exposure to companies supporting exploration of outer space and the deep sea. Its holdings include businesses involved in aerospace, defense, communications, research, and related technologies.
Read more on ROKT →About Revolution Medicines Inc. Common Stock
Revolution Medicines develops precision medicines for cancer. Its programs focus on targeting RAS-driven cancers and related signaling pathways.
Read more on RVMD →
